Heritage Oaks Bank names new CEO
Simone Lagomarsino will take the reins at Paso Robles-based Heritage Oaks Bank as president and CEO on Sept. 10. Lagomarsino succeeds current CEO Larry Ward, who announced his retirement earlier this year. Heritage Oaks, the parent of the Business First Bank brand in Santa Barbara, is the third-largest regionally based bank in the Tri-Counties. It Read More →
700 BofA jobs at stake in Ventura County
About 700 jobs in Thousand Oaks and Westlake Village are in peril as Bank of America prepares to sell or shutter the correspondent-lending arm of its mortgage business. “We intend to sell the correspondent mortgage lending division or, if a suitable deal is not identified, we will consider other options, including winding down the correspondent Read More →
NiMin drums up $4M
NiMin Energy Corp., an independent oil company based in Carpinteria, has raised $4 million in a private placement with an Australian bank. NiMin owns and drills onshore oil fields near Bakersfield and in Wyoming and southern Louisiana. It said the money will go toward developing its assets near Bakersfield. NiMin said it sold 2.7 million Read More →
Semtech, QAD earnings increase
Semtech earns $27.1M, amps up repurchase program Semtech Corp. said Aug. 25 that it earned $27.1 million in second-quarter profits and that it would expand its stock repurchase plan by $36 million. The board of the Camarillo-based semiconductor firm had previously authorized $14 million as part of the plan to buy back stock. Semtech saw Read More →
Inphi shares plummet 17% in after-hours trading
Shares of Inphi Corp. soared more than 13 percent in day trading on Aug. 23, before plummeting almost 17 percent in after-hours trading as the company issued a statement saying it’s lowering its revenue outlook for the second half of the year. The semiconductor company said in a statement that it has recently become aware Read More →
Amgen expects approval for Xgeva as bone treatment in April
Thousand Oaks-based Amgen said Aug. 22 that the U.S. Food and Drug Administration will likely make a decision by April 26, 2012 on the biotech firm’s application to expand the use of its Xgeva bone treatment drug to treat advanced prostate cancer. Amgen, the largest biotech company in the world, said in a statement that Read More →
